New: BPC-157, TB-500, Epitalon and SemaxExplore
Mineral mist enters a glass nasal passage beside a separate unlit skin-tissue route
Rebody Blog

Semax Nasal Spray vs Injection: Which Route Has Better Evidence?

Nasal Semax is the clear route choice because Rebody's spray matches the direct human experiment and avoids injection handling.

Nick Locascio

Written byNick Locascio

This article is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional about your health or before changing treatment. Do not delay medical care because of something you read here.

Nasal Semax is the clear route choice. Rebody's spray matches the direct human Semax experiment and avoids injection handling.

Update, October 2026: Semax is now available. Log in to your Rebody account to speak with a clinician and get started. Some information below may be out of date.

Semax nasal spray, injected Semax, and NAD+ nasal spray differ by molecule, route, and trackable outcome. For Semax itself, the nasal route has the cleanest evidence chain.

Comparison at a glance

Option Best reason to consider it Product facts Most relevant evidence Verdict
Semax nasal spray Direct match to the human Semax route Product guide covers concentration, supply, storage, and price 24-person intranasal resting-state fMRI experiment Clear route winner
Injected Semax Different route Rebody does not offer it No direct administered-human Semax study in this source set Not the evidence-matched route
NAD+ nasal spray Current nasal option for direct NAD+ intent 300 mg/mL, 12 mL, 30 days, $59.50 first month, then $119/month NAD biology, not Semax evidence Available but not a Semax substitute

Nasal wins the Semax route question. Rebody's product and the direct human experiment are both intranasal.

The decisive distinction

The route verdict is unusually clean: intranasal Semax has the direct human experiment, matches Rebody's product, and removes needles and sharps disposal.

What Semax is

Semax is a synthetic seven-amino-acid peptide with the sequence Met–Glu–His–Phe–Pro–Gly–Pro, related to an ACTH fragment without the adrenal-hormone sequence. Rebody's Semax format is a prescription nasal spray. This identity keeps similar names, salts, precursors, endogenous physiology, and finished products from being compared as though they were one molecule.

Keep each result with its tested molecule and route. The intranasal experiment belongs to Semax nasal spray; injected peptides and NAD+ nasal spray carry their own evidence records.

What the strongest evidence measured

The strongest human experiment assigned 14 healthy adults to intranasal 1% Semax and 10 to placebo. Resting-state fMRI collected before and shortly after the spray showed a larger rostral default-mode-network subcomponent. Separate rat experiments measured BDNF and trkB signaling in brain tissue after intranasal Semax. Together, those results make the nasal route the evidence-matched Semax choice.

For each option, name the molecule, route, population or model, duration, and endpoint. Then use storage, supply, and price to decide whether the evidence-matched option is practical.

Why the nasal route has the cleaner evidence chain

The direct human Semax experiment used an intranasal 1% solution and measured resting-state brain-network activity shortly afterward. Rebody's Semax product is also a nasal spray, creating a direct route match from experiment to finished format.

An injection changes absorption, peak exposure, storage, and the meaning of a milligram. The current source set offers no human pharmacokinetic or cognitive result that gives injected Semax an advantage over the evidence-matched nasal route.

Compare concentration per milliliter, bottle volume, days of supply, and after-opening storage.

Severe congestion, recurrent nosebleeds, or persistent nasal irritation can make a spray impractical. In that situation, the route needs reassessment; the current evidence does not turn injection into the Semax winner.

A needle-free bottle removes injection supplies and sharps. Congestion, travel, and storage still affect whether the spray is practical. Nasal Semax leads both the evidence match and the convenience comparison for most users.

Nasal spray is the only Semax route with direct human evidence here

Nasal wins because Rebody's route and the direct human Semax experiment are intranasal. The recommendation follows the exact molecule, route, population, duration, and measured endpoint.

When another option is better

Another peptide injection is the better comparison when the real question concerns that molecule's own research. NAD+ nasal spray is better when the goal is direct NAD and cellular-energy support.

For Semax specifically, nasal spray is the evidence-matched route. NAD+ spray is available today, but it is a different compound rather than a substitute route for Semax.

Route differences

The routes represented by Semax nasal spray, adjacent peptide injections, NAD+ nasal spray create different work: sprays require tolerance of nasal irritation; injections require storage, supplies, and sharps disposal.

Never match milligrams across the routes used by Semax nasal spray, adjacent peptide injections, NAD+ nasal spray. Exposure depends on formulation and route. A switch requires a new prescription, not an internet conversion table.

What to track

Your clinician sets the dose, timing, and use. Follow your prescription label. To track results, pick one repeatable focus, proofreading, or recall task under similar sleep, caffeine, and meal conditions.

A useful log for Semax nasal spray, adjacent peptide injections, NAD+ nasal spray also records the confounders most likely to create an apparent result. The record helps you and your clinician decide whether to continue, change the plan, or investigate another cause.

Price, supply, and refills

Current Rebody prices: NAD+ nasal spray is listed as 300 mg/mL in a 12 mL, 30-day bottle for $59.50 first month, then $119/month. Prices and packages can change; confirm the current product page before starting.

The Semax guide brings the chemical form, concentration, supply, storage, and price together.

Storage, shipping, and travel

Storage for Semax nasal spray, adjacent peptide injections, NAD+ nasal spray follows each exact label. Ask about opening, heat, freezing, particles, cloudiness, separation, broken seals, and leaking pumps instead of transferring one spray's or vial's rule to another product.

Travel with Semax nasal spray, adjacent peptide injections, NAD+ nasal spray in each product's labeled container. Cold products need their specified range without direct ice contact; injections need supplies and sharps planning; nasal bottles stay capped and unshared; tablets and troches stay dry.

Side effects and urgent symptoms

Safety for Semax nasal spray, adjacent peptide injections, NAD+ nasal spray starts with the route: nasal irritation, congestion, unpleasant taste, or nosebleed for sprays; pain, redness, swelling, bruising, or infection for injections. Finished instructions add ingredient-specific interactions and exclusions.

With Semax nasal spray, adjacent peptide injections, NAD+ nasal spray, breathing trouble, facial or throat swelling, fainting, severe chest pain, a spreading reaction, major neurologic symptoms, or serious-infection signs need urgent help. Do not use a damaged product while waiting for an online answer.

What the route evidence supports

Intranasal Semax changed resting-state brain-network activity in 24 healthy adults. Rat studies add BDNF and trkB signaling findings. Together they support intranasal Semax as a cognition-research route while keeping focus, memory, and work-performance claims tied to studies that measure those outcomes directly.

Open questions about Semax routes

The source set contains no head-to-head study of nasal and injected Semax. None of these papers measured blood levels after each route, compared how fast an effect starts, or checked which route gives steadier exposure. The human fMRI study also used one nasal solution, so it says nothing about how a different concentration or spray device would perform.

That gap cuts both ways. It does not prove that an injection would be weaker. It does mean that a claim of a "stronger" injection, or one that "reaches the brain better," has no human data behind it here. The nasal route keeps its lead because researchers tested it and Rebody intends to offer it. Injection was never tested and found lacking; it was simply not tested.

Questions people ask

What are the benefits of Semax nasal spray?

The direct human evidence is a 24-person intranasal fMRI experiment that measured a resting-state brain-network change. Rat studies measured BDNF and trkB signaling. Those findings make intranasal Semax a cognition-research route; memory, focus, and work performance remain separate outcomes for future human studies.

Who should not use Semax?

Your clinician reviews health history, medicines, and the ingredient list for the exact Semax product; NAD+, B12, and other peptide instructions do not apply.

What are the side effects of Semax intranasal?

Intranasal products can cause burning, congestion, irritation, unpleasant taste, or nosebleeds. Human Semax safety information is limited, so severe headache, neurologic change, unusual bleeding, facial swelling, breathing trouble, or another serious reaction needs prompt medical attention. Route-specific reactions must be assessed separately for each product in the comparison.

Is injected Semax stronger than the nasal spray?

No study in this source set compares the two routes in people. Claims that an injection is stronger rest on assumptions, not on measured blood levels or cognitive outcomes. The tested route is intranasal.

Can I switch from a Semax injection to the nasal spray?

Ask your clinician. A route change is a new prescription with its own concentration and label. Milligrams on one route do not convert to the other.

Why does Rebody plan a nasal spray instead of an injection?

The direct human Semax experiment used the nose, and a spray removes needles, supplies, and sharps disposal. That route match keeps the finished product tied to the evidence.

Access and buying questions

For Semax nasal spray, adjacent peptide injections, NAD+ nasal spray, ask for active ingredient and chemical form, formulation, concentration, route, container size, supply, storage, beyond-use date, package price, refills, and states. Those facts beat “medical grade” or “research grade” adjectives.

For Semax nasal spray, adjacent peptide injections, NAD+ nasal spray, avoid mystery vials, research-only products intended for personal use, copied certificates without a matching finished product, and charts that stand in for a patient label. A committee headline cannot verify the prescription in hand.

Compare each finished product by package price, supply days, monthly equivalent, supplies, shipping, and refill timing. A research paper cannot supply missing commercial details.

Decisive bottom line

Nasal Semax is the clear route choice because Rebody's spray matches the direct human experiment and avoids injection handling. Use the Semax guide to compare concentration, supply, storage, and full price, then track one repeatable cognition task.

Keep reading

Primary sources